Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
McKesson
Johnson and Johnson
Express Scripts
Merck

Last Updated: January 31, 2023

Litigation Details for Intercept Pharmaceuticals, Inc. v. Apotex Inc. (D. Del. 2020)


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Small Molecule Drugs cited in Intercept Pharmaceuticals, Inc. v. Apotex Inc.
The small molecule drug covered by the patents cited in this case is See Plans and Pricing .

Details for Intercept Pharmaceuticals, Inc. v. Apotex Inc. (D. Del. 2020)

Date Filed Document No. Description Snippet Link To Document
2022-02-02 115 Joint Claim Construction Brief “’673 Patent” refers to U.S. Patent No. 9,238,673.  “’117 Patent” refers to U.S. Patent No. 10,047,117…“’073 Patent” refers to U.S. Patent No. 10,174,073.  “’337 Patent” refers to U.S. Patent No. 10,052,337…“’349 Patent” refers to U.S. Patent No. 10,751,349.  “’549 Patent” refers to U.S. Patent No. 10,758,549…compositions—expire. Patents from three patent families are asserted in this case. The ’673 Patent Family, which…and ’073 Patents, and the ’337 Patent Family, which includes the ’337, ’349, and ’549 Patents. The ’673 External link to document
2022-02-27 137 Claim Construction Chart regarding U.S. Patent No. 9,238,673 (“the ’673 Patent”), U.S. Patent No. 10,047,117 (“the ’117 Patent”), U.S.…U.S. Patent No. 10,174,073 (“the ’073 Patent”), U.S. Patent No. 10,052,337 (“the ’337 Patent”), U.S. Patent… ’349 Patent”), and U.S. Patent No. 10,758,549 (“the ’549 Patent”) (collectively, the “Patents-in-Suit…particles 1 U.S. Patent No. RE48,286 (“the RE286 Patent”) is also an asserted patent in this case. It … ’673 Patent (claims 1–23) ’073 Patent (claims External link to document
2022-03-23 142 Order - -Memorandum and Order terms of U.S. Patent Nos. 9,238,673 (“the ’673 Patent”), 10,047,117 (“the ’117 Patent”), 10,174,073 …of the ’673 Patent, the ’117 Patent, the ’337 Patent, the ’349 Patent, and the ’549 Patent are construed…10,174,073 (“the ’073 Patent”), 10,052,337 (“the ’337 Patent”), 10,751,349 (“the ’349 Patent”), and 10,758,549… matter” (’337 Patent, claims 1–8; ’349 Patent, claims 1, 19; ’549 Patent, …meaning (’337 patent, claim 11; ’349 patent, claim 4; ’549 patent, claims 12, 23 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Harvard Business School
Moodys
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.